2023年世界变态反应组织（WASOG）会议亮点。
WASOG 2023 conference highlights.
作者信息
Chuquimia Olga D, Rivera Natalia V
机构信息
Karolinska Institutet.
出版信息
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Sep 24;41(3):e2024045. doi: 10.36141/svdld.v41i3.16196.
Abstract
The World Association of Sarcoidosis and Other Granulomatous Diseases (WASOG) 2023 conference held in Stockholm, Sweden, focused on disseminating the science and updating the interstitial lung diseases (ILDs) community with the latest science and concepts in precision medicine. This article summarizes the first four sessions of the conference that focused on disease and phenotype characterization, genetics in population cohorts, uses of biobanks and big data, epidemiology in diverse racial and ethnic groups, and data-driven applications that can be applicable to move the ILD field toward precision medicine.
摘要
结节病和其他肉芽肿性疾病世界协会（WASOG）2023年会议在瑞典斯德哥尔摩举行，重点是传播科学知识，并向间质性肺疾病（ILDs）领域介绍精准医学的最新科学和概念。本文总结了会议的前四场会议，内容聚焦于疾病和表型特征、人群队列中的遗传学、生物样本库和大数据的应用、不同种族和族裔群体的流行病学，以及可推动ILD领域迈向精准医学的数据驱动型应用。
相似文献
1
WASOG 2023 conference highlights.2023年世界变态反应组织（WASOG）会议亮点。
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Sep 24;41(3):e2024045. doi: 10.36141/svdld.v41i3.16196.
2
Abstracts of the 1st International WASOG Conference on Diffuse Lung Diseases and the 7th Conference of the Italian Chapter of WASOG (World Association of Sarcoidosis and Other Granulomatous Disorders). June 7-9, 2001. Venice Lido, Italy.第一届国际WASOG弥漫性肺部疾病会议暨WASOG（结节病及其他肉芽肿性疾病世界协会）意大利分会第七届会议摘要。2001年6月7日至9日。意大利威尼斯丽都。
Sarcoidosis Vasc Diffuse Lung Dis. 2001 May;18 Suppl 1:19-63.
3
ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly.2019年欧洲呼吸学会国际大会：间质性肺疾病专题会议亮点
ERJ Open Res. 2020 Oct 5;6(4). doi: 10.1183/23120541.00143-2020. eCollection 2020 Oct.
4
Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects.印度间质性肺疾病的发病率、患病率和全国负担：两项 3089 例受试者研究的估计值。
PLoS One. 2022 Jul 21;17(7):e0271665. doi: 10.1371/journal.pone.0271665. eCollection 2022.
5
Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.在美国大型理赔数据库分析中估计的具有进行性表型的慢性纤维性间质性肺疾病的患病率和发病率。
Adv Ther. 2021 Jul;38(7):4100-4114. doi: 10.1007/s12325-021-01786-8. Epub 2021 Jun 17.
6
Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.尼达尼布：在纤维化间质性肺疾病中的研究进展。
Drugs. 2021 Apr;81(5):575-586. doi: 10.1007/s40265-021-01487-0. Epub 2021 Mar 25.
7
World Trade Center Health Program best practices for the diagnosis and treatment of fibrosing interstitial lung diseases.世界贸易中心健康计划纤维性间质性肺疾病的诊断和治疗最佳实践。
Arch Environ Occup Health. 2023;78(4):232-235. doi: 10.1080/19338244.2023.2166007. Epub 2023 Jan 12.
8
9
10
Health care costs and utilization of progressive fibrosing lung disease by underlying interstitial lung disease type.按潜在间质性肺疾病类型划分的进展性肺纤维化疾病的医疗费用和利用情况。
J Manag Care Spec Pharm. 2024 Feb 3;30(2):163-174. doi: 10.18553/jmcp.2024.30.2.163.
本文引用的文献
1
D. Geraint James Lecture: The sarcoidosis saga: what insights from the past will guide us in the future.D. 杰兰特·詹姆斯讲座：结节病传奇：过去的哪些见解将在未来指引我们。
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Dec 20;40(4):e2023057. doi: 10.36141/svdld.v40i4.15282.
2
Establishing a Diagnosis of Pulmonary Sarcoidosis.确立肺结节病的诊断
J Clin Med. 2023 Nov 2;12(21):6898. doi: 10.3390/jcm12216898.
3
MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.MUC5B rs35705950 次要等位基因与特发性肺纤维化的年龄较大和生存较好相关。
Respirology. 2023 May;28(5):455-464. doi: 10.1111/resp.14440. Epub 2022 Dec 26.
4
Dysbiosis, malnutrition and enhanced gut-lung axis contribute to age-related respiratory diseases.肠道菌群失调、营养不良和增强的肠-肺轴导致与年龄相关的呼吸疾病。
Ageing Res Rev. 2021 Mar;66:101235. doi: 10.1016/j.arr.2020.101235. Epub 2020 Dec 13.
5
Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study.端粒长度与特发性肺纤维化和慢性阻塞性肺疾病风险：一项孟德尔随机研究。
Lancet Respir Med. 2021 Mar;9(3):285-294. doi: 10.1016/S2213-2600(20)30364-7. Epub 2020 Nov 13.
6
Emerging phenotypes of sarcoidosis based on 18F-FDG PET/CT: a hierarchical cluster analysis.基于 18F-FDG PET/CT 的结节病新兴表型：层次聚类分析。
Expert Rev Respir Med. 2020 Feb;14(2):229-238. doi: 10.1080/17476348.2020.1684902. Epub 2019 Oct 29.
7
Dysbiosis and the immune system.肠道菌群失调与免疫系统。
Nat Rev Immunol. 2017 Apr;17(4):219-232. doi: 10.1038/nri.2017.7. Epub 2017 Mar 6.
8
High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences.高密度基因图谱鉴定结节病表型中的新易感变异并显示基因组驱动的表型差异。
Am J Respir Crit Care Med. 2016 May 1;193(9):1008-22. doi: 10.1164/rccm.201507-1372OC.
9
A multidimensional index and staging system for idiopathic pulmonary fibrosis.特发性肺纤维化的多维指数和分期系统。
Ann Intern Med. 2012 May 15;156(10):684-91. doi: 10.7326/0003-4819-156-10-201205150-00004.
10
Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.核工作人员中 HLA-DPB1 E69 基因型和铍暴露导致慢性铍病的风险。
Am J Respir Crit Care Med. 2011 Jun 15;183(12):1680-8. doi: 10.1164/rccm.201002-0254OC. Epub 2011 Mar 11.
Zotero 插件